These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33761267)

  • 1. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients.
    Wang X; Zhu X
    Cancer Biother Radiopharm; 2022 Nov; 37(9):837-842. PubMed ID: 33761267
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
    Luo L; Gao Y; Sun X
    Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of forkhead box Q1 transcription factor in ovarian epithelial carcinomas.
    Gao M; Shih IeM; Wang TL
    Int J Mol Sci; 2012 Oct; 13(11):13881-93. PubMed ID: 23203039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L; Chen H; Ding B; Jiang W
    J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
    Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
    J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a.
    Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M
    Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer.
    Han GH; Yun H; Chung JY; Kim JH; Cho H
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36999629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis.
    Fang YN; Huang ZL; Li H; Tan WB; Zhang QG; Wang L; Wu JL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5127-5133. PubMed ID: 30178832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA ABCB10 correlates with advanced clinicopathological features and unfavorable survival, and promotes cell proliferation while reduces cell apoptosis in epithelial ovarian cancer.
    Chen Y; Ye X; Xia X; Lin X
    Cancer Biomark; 2019; 26(2):151-161. PubMed ID: 31381507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer.
    Li Y; Zhu X; Liu C; Han Q; Chen X; Liu Y; Yin Y; He A; Xia F
    Medicine (Baltimore); 2021 Mar; 100(10):e24759. PubMed ID: 33725831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.
    Deng Y; Liu L; Feng W; Lin Z; Ning Y; Luo X
    Recent Pat Anticancer Drug Discov; 2021; 16(4):533-539. PubMed ID: 34551701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
    BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
    Ma SY; Wei P; Qu F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer.
    Cybulski M; Jeleniewicz W; Nowakowski A; Stenzel-Bembenek A; Tarkowski R; Kotarski J; Stepulak A
    Anticancer Res; 2015 Feb; 35(2):1115-9. PubMed ID: 25667501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of lnc-MyD88 and its relationship with the prognosis of patients with epithelial ovarian cancer].
    Zhu Y; Huang JM; Zhang GN; Li JM; Huang J
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):117-124. PubMed ID: 35184472
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased expression of FOXQ1 is a prognostic marker for patients with gastric cancer.
    Liang SH; Yan XZ; Wang BL; Jin HF; Yao LP; Li YN; Chen M; Nie YZ; Wang X; Guo XG; Wu KC; Ding J; Fan DM
    Tumour Biol; 2013 Oct; 34(5):2605-9. PubMed ID: 23609035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.